Ikonisys SA AI Stock Analysis
Ikonisys SA (9W8) AI Stock Analysis
Ikonisys SA
(Frankfurt:9W8)
No summary available
Ikonisys SA (9W8) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 23.05M
- Dividend Yield
- ―
- Average Volume (3M)
- ―
- Price to Earnings (P/E)
- -5.3
- Beta (1Y)
- 0.07
- Revenue Growth
- 37.28%
- EPS Growth
- 7.83%
- Country
- Germany
- Employees
- 15
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Devices
Ikonisys SA Business Overview & Revenue Model
Company Description
Based in Paris, France, Ikonisys S.A. is a company specializing in cell-based diagnostics. It develops, produces, and commercializes medical diagnostic solutions for various cancers across the United States and Europe. Their core offering includes th...
Ikonisys SA Peers Comparison
Overall Rating
FR:ALERS58Neutral
FR:ALMKT45Neutral
FR:ALNOV45Neutral
FR:ALMDT43Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 58Neutral | EUR 258.89M | 37.64 | 3.89% | ― | 6.28% | 204.56% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 45Neutral | EUR 17.81M | 1.44 | -157.72% | ― | 3.38% | ― | |
| 45Neutral | EUR 32.66M | -0.78 | -159.70% | ― | 10.36% | 29.41% | |
| 43Neutral | EUR 209.76M | -3.48 | 271.64% | ― | 2.16% | -5.26% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:9W8 | Ikonisys SA | 1.36 | 0.02 | 1.12% | |
| FR:ALMKT | MAUNA KEA TECHNOLOGIES | 0.09 | 0.01 | 10.98% | |
| FR:ALNOV | Novacyt S.A. | 0.45 | 0.02 | 3.45% | |
| FR:ALERS | Eurobio-Scientific SA | 26.35 | 2.20 | 9.11% | |
| FR:ALDMS | Diagnostic Medical Systems | 0.91 | -0.36 | -28.19% | |
| FR:ALMDT | Median Technologies | 4.28 | 1.35 | 45.83% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
